Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure. (TORAFIC)

This study has been completed.
Sponsor:
Information provided by:
Ferrer Internacional S.A.
ClinicalTrials.gov Identifier:
NCT00409942
First received: December 11, 2006
Last updated: July 14, 2009
Last verified: June 2009